Curelator

Curelator is a Boston-based digital health company founded in 2013, focused on transforming migraine care through its N1-Headache platform. The company leverages prospective digital diary data and advanced analytics to enable personalized medicine, helping patients discover their unique triggers and allowing clinicians to monitor treatment efficacy. Curelator has established a research-focused model, collaborating with leading neurologists to publish clinical studies that validate its approach and deepen the scientific understanding of migraine. Its business model appears to be B2B2C, offering the platform to patients via healthcare provider codes.

N1-Headache digital health platform comprising a patient mobile app for daily symptom/factor tracking and a clinician web dashboard. Uses proprietary analytics to perform longitudinal, within-subject analysis to identify personalized migraine risk factors and track treatment response.

Curelator operates in the competitive digital health space for migraine, competing with direct-to-consumer tracking apps (e.g., Migraine Buddy) and broader chronic condition platforms. Its key differentiator is a strong focus on clinical validation, personalized within-subject analytics (vs. population-level insights), and a deliberate B2B2C strategy targeting healthcare providers. It also competes with EHR-integrated digital tools and telemedicine services offering headache care.